Clinical trial
Carvedilol for Prevention of Paroxysmal Atrial Fibrillation
NCT01608893 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Carvedilol for Prevention of Paroxysmal Atrial Fibrillation
- Lead sponsor
- University of Calgary
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 31, 2012
- Completion date
- June 30, 2025
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.